Skip to main content

Volume 14 Supplement 1

Proceedings of the 2019 International Conference on Intelligent Computing (ICIC 2019): medical genomics


Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares no competing interests.

Nanchang, China3-6 August 2019

Conference website

Edited by De-Shuang Huang.

  1. Hepatocellular carcinoma (HCC) is one of the most common cancers. The discovery of specific genes severing as biomarkers is of paramount significance for cancer diagnosis and prognosis. The high-throughput omi...

    Authors: Zishuang Zhang and Zhi-Ping Liu

    Citation: BMC Medical Genomics 2021 14(Suppl 1):112

    Content type: Research

    Published on:

  2. Clinically, behavior, cognitive, and mental functions are affected during the neurodegenerative disease progression. To date, the molecular pathogenesis of these complex disease is still unclear. With the rapi...

    Authors: Xue Jiang, Miao Chen, Weichen Song and Guan Ning Lin

    Citation: BMC Medical Genomics 2021 14(Suppl 1):141

    Content type: Research

    Published on:

  3. Huntington’s disease is a kind of chronic progressive neurodegenerative disease with complex pathogenic mechanisms. To data, the pathogenesis of Huntington’s disease is still not fully understood, and there ha...

    Authors: Xue Jiang, Weihao Pan, Miao Chen, Weidi Wang, Weichen Song and Guan Ning Lin

    Citation: BMC Medical Genomics 2021 14(Suppl 1):173

    Content type: Research

    Published on:

Annual Journal Metrics


As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.